NCT05985837View on ClinicalTrials.gov

Post Market Clinical Follow-Up Study - Medical Device KalobaGOLA ( PMCF )

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

August 2, 2023

Primary Completion Date

October 31, 2023

Study Completion Date

October 31, 2023

Conditions
Sore-throatPharyngitis
Interventions
DEVICE

KalobaGOLA spray (1)

Oral spray, 2-4 spray, till 8 times per day

DEVICE

KalobaGOLA spray (2)

Oral spray, 2-4 spray, till 4 times per day

DEVICE

KalobaGOLA tablets

1 tablets, 6 times per day

Trial Locations (1)

39044

Schwabe Pharma Italia, Neumarkt

All Listed Sponsors
lead

Schwabe Pharma Italia

INDUSTRY